These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24697529)

  • 1. Statistical methods for active pharmacovigilance, with applications to diabetes drugs.
    Zhuo L; Farrell PJ; McNair D; Krewski D
    J Biopharm Stat; 2014; 24(4):856-73. PubMed ID: 24697529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mining pharmacovigilance data using Bayesian logistic regression with James-Stein type shrinkage estimation.
    An L; Fung KY; Krewski D
    J Biopharm Stat; 2010 Sep; 20(5):998-1012. PubMed ID: 20721787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Representativeness of diabetes patients participating in a web-based adverse drug reaction monitoring system.
    Härmark L; Alberts S; van Puijenbroek E; Denig P; van Grootheest K
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):250-5. PubMed ID: 22933342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions in older adults: a retrospective study from pharmacovigilance.
    Charfi R; El Aïdli S; Zaïem A; Kastalli S; Sraïri S; Daghfous R; Lakhal M
    Therapie; 2012; 67(5):471-6. PubMed ID: 23241257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of diabetes in france and drug use: study based on the French pharmacovigilance database].
    Berthet S; Grolleau S; Brefel-Courbon C; Montastruc JL; Lapeyre-Mestre M
    Therapie; 2007; 62(6):483-8. PubMed ID: 18316014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance.
    Zink RC; Huang Q; Zhang LY; Bao WJ
    Chin J Nat Med; 2013 May; 11(3):314-20. PubMed ID: 23725848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug safety data mining with a tree-based scan statistic.
    Kulldorff M; Dashevsky I; Avery TR; Chan AK; Davis RL; Graham D; Platt R; Andrade SE; Boudreau D; Gunter MJ; Herrinton LJ; Pawloski PA; Raebel MA; Roblin D; Brown JS
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):517-23. PubMed ID: 23512870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program.
    Awada Z; Zgheib NK
    Pharmacogenomics; 2014 Apr; 15(6):845-56. PubMed ID: 24897290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribed medicines for elderly frail people with diabetes resident in nursing homes-issues of polypharmacy and medication costs.
    Gadsby R; Galloway M; Barker P; Sinclair A
    Diabet Med; 2012 Jan; 29(1):136-9. PubMed ID: 22004423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.
    Oliveira JL; Lopes P; Nunes T; Campos D; Boyer S; Ahlberg E; van Mulligen EM; Kors JA; Singh B; Furlong LI; Sanz F; Bauer-Mehren A; Carrascosa MC; Mestres J; Avillach P; Diallo G; Díaz Acedo C; van der Lei J
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):459-67. PubMed ID: 23208789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious adverse drug reactions in older adults notified to pharmacovigilance.
    Charfi R; El Aïdli S; Zaïem A; Kastalli S; Sraïri S; Daghfous R; Lakhal M
    Therapie; 2012; 67(5):465-70. PubMed ID: 23241256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system.
    Chen CJ; Cheng CF; Lin HY; Hung SP; Chen WC; Lin MS
    J Clin Pharm Ther; 2012 Dec; 37(6):647-51. PubMed ID: 22646235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using electronic medical record data to characterize the level of medication use by age-groups in a network of primary care clinics.
    Freund J; Meiman J; Kraus C
    J Prim Care Community Health; 2013 Oct; 4(4):286-93. PubMed ID: 24327665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.
    Raschi E; Piccinni C; Poluzzi E; Marchesini G; De Ponti F
    Acta Diabetol; 2013 Aug; 50(4):569-77. PubMed ID: 22008948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre.
    Shalviri G; Yousefian S; Gholami K
    J Clin Pharm Ther; 2012 Aug; 37(4):448-51. PubMed ID: 22122488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.
    Fabiano V; Mameli C; Zuccotti GV
    Expert Opin Drug Saf; 2012 Jan; 11(1):95-105. PubMed ID: 21548838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study.
    González-Rubio F; Calderón-Larrañaga A; Poblador-Plou B; Navarro-Pemán C; López-Cabañas A; Prados-Torres A
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1287-94. PubMed ID: 21702073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of musculoskeletal complaints and gliptin use: review of spontaneous reports.
    Tarapués M; Cereza G; Figueras A
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1115-8. PubMed ID: 23960039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.